SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-21-243671
Filing Date
2021-08-12
Accepted
2021-08-11 19:27:53
Documents
2
Group Members
GILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS X, LLCKEVAL DESAIKHALED A. NASR

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d391686dsc13da.htm SC 13D/A 119582
2 EX-99.A d391686dex99a.htm EX-99.A 5987
  Complete submission text file 0001193125-21-243671.txt   127377
Mailing Address C/O INTERWEST PARTNERS 467 FIRST STREET SUITE 201 LOS ALTOS CA 94022
Business Address C/O INTERWEST PARTNERS 467 FIRST STREET SUITE 201 LOS ALTOS CA 94022 650-854-8585
INTERWEST PARTNERS X LP (Filed by) CIK: 0001443898 (see all company filings)

IRS No.: 263131621 | State of Incorp.: CA
Type: SC 13D/A

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Subject) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88806 | Film No.: 211165126
SIC: 2836 Biological Products, (No Diagnostic Substances)